OTCMKTS:EXDI Exactus (EXDI) Stock Price, News & Analysis → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free EXDI Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.07▼$0.0752-Week Range N/AVolume257,300 shsAverage Volume83,144 shsMarket Capitalization$38.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Exactus alerts: Email Address Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. About Exactus Stock (OTCMKTS:EXDI)Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.Read More Ad Priority GoldBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...Get your free information kit NOW, before it's too late. EXDI Stock News HeadlinesApril 25, 2024 | americanbankingnews.comHead-To-Head Survey: Exactus (OTCMKTS:EXDI) versus biote (NASDAQ:BTMD)February 7, 2024 | news.yahoo.comClapham chemical attack – live: Suspect Abdul Ezedi was ‘very angry’ after sister was shot deadMay 1, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.June 4, 2023 | investing.comStarbreeze AB B (STZEb)October 30, 2021 | finanznachrichten.deExactus Inc.: CBD Company Panacea Life Sciences Sees Promise as Denver Airport Reaches Third-Highest Passenger Traffic in WorldOctober 26, 2021 | finance.yahoo.comExactus, Inc. to Present at BIO CEO & Investor ConferenceOctober 15, 2021 | finanznachrichten.deExactus Inc.: Grand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State UniversityOctober 14, 2021 | finance.yahoo.comGrand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State UniversitySee More Headlines Receive EXDI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exactus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolOTCMKTS:EXDI CUSIPN/A CIK1552189 Webwww.exactusinc.com Phone804-205-5036FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,460,000.00 Net MarginsN/A Pretax Margin-15,131.74% Return on Equity-3,272.69% Return on Assets-185.29% Debt Debt-to-Equity RatioN/A Current Ratio1.32 Quick Ratio0.82 Sales & Book Value Annual Sales$2.07 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / BookN/AMiscellaneous Outstanding Shares599,005,000Free Float209,652,000Market Cap$38.94 million OptionableNot Optionable Beta4.21 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesEmiliano AloiPresident and Interim CEOKenneth E. PuzderChief Financial Officer and DirectorAndrew JohnsonChief Strategy OfficerBobby YampolskyInterim ChairmanKey CompetitorsNatural Alternatives InternationalNASDAQ:NAIIBright GreenNASDAQ:BGXXMannatechNASDAQ:MTEXIM CannabisNASDAQ:IMCCMariMedOTCMKTS:MRMDView All Competitors EXDI Stock Analysis - Frequently Asked Questions When did Exactus' stock split? Exactus shares reverse split before market open on Thursday, October 28th 2021. The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. What other stocks do shareholders of Exactus own? Based on aggregate information from My MarketBeat watchlists, some companies that other Exactus investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO). How do I buy shares of Exactus? Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EXDI) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority Gold😱 This phenomenon is smashing regular market gainsMillPubElon’s New Device is About to Shock the WorldInvestorPlaceYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingA once-in-a-century investment opportunityStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exactus Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.